# Hoth Therapeutics (stock symbol: HOTH) Logo in transparent PNG and SVG formats

## Hoth Therapeutics Logo large

### Hoth Therapeutics Logo large Download PNG (30.1 KB)

![Hoth Therapeutics Logo large Download PNG (30.1 KB)](/img/orig/HOTH_BIG-0aac79d4.png)

### Hoth Therapeutics Logo large Download SVG (7.23 KB)

![Hoth Therapeutics Logo large Download SVG (7.23 KB)](/img/orig/HOTH_BIG-6d6e7b0c.svg)

## Hoth Therapeutics Logo icon format

### Hoth Therapeutics Logo icon format Download PNG (115.38 KB)

![Hoth Therapeutics Logo icon format Download PNG (115.38 KB)](/img/orig/HOTH-9e8f1b0b.png)

### Hoth Therapeutics Logo icon format Download SVG (5.5 KB)

![Hoth Therapeutics Logo icon format Download SVG (5.5 KB)](/img/orig/HOTH-6d525de2.svg)

## Hoth Therapeutics Logo large for dark backgrounds

### Hoth Therapeutics Logo large for dark backgrounds Download PNG (29.87 KB)

![Hoth Therapeutics Logo large for dark backgrounds Download PNG (29.87 KB)](/img/orig/HOTH_BIG.D-2d09e13c.png)

### Hoth Therapeutics Logo large for dark backgrounds Download SVG (7.21 KB)

![Hoth Therapeutics Logo large for dark backgrounds Download SVG (7.21 KB)](/img/orig/HOTH_BIG.D-0742b682.svg)

## About Hoth Therapeutics

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; ZylÃ¶ Therapeutics, Inc., and the University of Cincinnati. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

1. Website domain: hoththerapeutics.com
2. Employees: 4
3. Marketcap: $5.71 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
